The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...

Jenny Ahlstrom knows firsthand the difficulty of finding a clinical trial quickly to stave off fast-hitting diseases and also matching up with one for which you're eligible. She was diagnosed with ...

The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical (and solvable) issue is finding, ...

Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...

Bringing a drug to market is a long and onerous process. Studies estimate that the clinical trial process — where new drugs are tested on patients before they are approved — lasts nine years and costs ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

How pharma–hospital partnerships can overcome operational, financial, and organizational barriers to build high-performing clinical trial programs that expand access, accelerate accrual, and ...

Beccy holds a PhD in Biological Science, a Master’s in Molecular Biology of Parasites and Disease Vectors, and a Bachelor’s in Human Biology and Forensic Science. Beccy holds a PhD in Biological ...

Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...